Clinical Trial Update: Efficacy, Safety and Pharmacokinetics Study of CPL207280 After 2-weeks Administration in Subjects With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating efficacy, safety, and pharmacokinetics of CPL207280 in subjects with Type 2 Diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CPL207280

Snippet

Sponsor: Celon Pharma SA | Conditions: Type 2 Diabetes | Phase 2 | Status: UNKNOWN